The study findings may help guide decision-making for clinicians caring for patients who receive hemodialysis or kidney transplant with severe secondary hyperparathyroidism.
The effect of cholecalciferol supplementation on parathyroid hormone levels and bone loss at the lumbar spine in kidney transplant recipients was studied in a placebo-controlled trial.
A recent findings, if validated, may partly explain inter-individual differences in the response to cinacalcet treatment for secondary hyperparathyroidism.
Magnesium homeostasis in CKD-MBD been the subject of increasing attention because it plays an important role in the pathophysiology of cardiovascular disease and bone health, according to investigators.
